Newsletters
The Altascientist
THE ALTASCIENTIST, ISSUE NO. 8
Facing bioanalytical challenges when evaluating the immunogenicity profile of protein-based therapeutic drugs
SELECT A CATEGORY BELOW
NEWSLETTERS
-
Newsletter
March 2019
Bold new look, how to overcome bioanalytical challenges, and case studies on hybrid medicines, 505(b)(2), and drug interactions
-
Newsletter
September 2018
Get the Scoop – A case study evaluating the abuse potential of Mirogabalin, news on our upcoming acquisition, the top trends influencing the CRO industry, and more!
-
Newsletter
April 2018
Get the Scoop – A case study on cannabis, our latest assay list, and much more!
-
Newsletter
January 2018
GET THE SCOOP — Up Close and Personal with our CEO and 5 Ways to Save Money on Outsourcing
-
Newsletter
June 2017
Guideline on Equivalence Studies, Metabolic Disorders and your chance to ask our experts questions directly about hot topics like Biotherapeutics and Therapeutic Equivalence.
-
Newsletter
February 2017
Learn about our cannabis study, biosimilars, our diabetes case studies, and so much more!
-
Newsletter
December 2016
On December 2nd, the FDA published a guidance intended to assist applicants in preparing the clinical pharmacology section of prescription drug labeling.